Zacks Research Predicts Lower Earnings for Procter & Gamble

The Procter & Gamble Company (NYSE:PG) – Equities research analysts at Zacks Research cut their Q3 2025 earnings per share estimates for shares of Procter & Gamble in a research note issued on Thursday, February 6th. Zacks Research analyst R. Lohia now forecasts that the company will post earnings per share of $1.58 for the quarter, down from their prior forecast of $1.60. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.91 per share. Zacks Research also issued estimates for Procter & Gamble’s Q4 2025 earnings at $1.53 EPS, FY2025 earnings at $6.92 EPS, Q1 2026 earnings at $2.01 EPS, Q2 2026 earnings at $2.02 EPS, Q3 2026 earnings at $1.69 EPS, Q1 2027 earnings at $2.14 EPS, Q2 2027 earnings at $2.13 EPS and FY2027 earnings at $7.82 EPS.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business had revenue of $21.88 billion during the quarter, compared to analysts’ expectations of $21.66 billion. During the same period in the previous year, the business earned $1.84 earnings per share. The business’s revenue was up 2.1% compared to the same quarter last year.

Other research analysts also recently issued research reports about the stock. Wells Fargo & Company upped their price target on shares of Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a research report on Thursday, January 23rd. DA Davidson reissued a “buy” rating and set a $209.00 target price on shares of Procter & Gamble in a report on Thursday, January 23rd. Evercore ISI lifted their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. UBS Group reduced their price objective on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Finally, Barclays lifted their target price on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $180.53.

Procter & Gamble Stock Performance

NYSE:PG opened at $169.53 on Monday. The company has a fifty day moving average of $167.06 and a two-hundred day moving average of $169.44. Procter & Gamble has a fifty-two week low of $153.52 and a fifty-two week high of $180.43. The stock has a market capitalization of $397.52 billion, a PE ratio of 26.99, a P/E/G ratio of 3.79 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s dividend payout ratio is presently 64.17%.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the transaction, the insider now owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 151,097 shares of company stock worth $25,635,076. Company insiders own 0.18% of the company’s stock.

Institutional Trading of Procter & Gamble

Hedge funds have recently made changes to their positions in the business. Syverson Strege & Co raised its position in Procter & Gamble by 19.5% in the 4th quarter. Syverson Strege & Co now owns 1,688 shares of the company’s stock valued at $283,000 after purchasing an additional 276 shares in the last quarter. Heritage Wealth Management Inc. CA increased its stake in shares of Procter & Gamble by 148.0% during the fourth quarter. Heritage Wealth Management Inc. CA now owns 1,602 shares of the company’s stock worth $269,000 after buying an additional 956 shares during the period. Zions Bancorporation N.A. raised its holdings in Procter & Gamble by 40.9% in the fourth quarter. Zions Bancorporation N.A. now owns 7,006 shares of the company’s stock valued at $1,175,000 after acquiring an additional 2,035 shares in the last quarter. TIAA Trust National Association grew its holdings in Procter & Gamble by 1.5% during the 4th quarter. TIAA Trust National Association now owns 331,846 shares of the company’s stock worth $55,634,000 after acquiring an additional 4,889 shares in the last quarter. Finally, Prospect Financial Group LLC purchased a new stake in shares of Procter & Gamble in the 4th quarter valued at approximately $271,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.